TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution August 20, 1982